Yan Qing
Director/Board Member at SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
Net worth: 8 M $ as of 2024-06-29
Network origin in Yan Qing first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 22 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Yan Qing via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| SICHUAN KELUN PHARMACEUTICAL CO., LTD. | Biotechnology | Founder Director/Board Member Chief Executive Officer Chairman Director of Finance/CFO Public Communications Contact Director/Board Member Corporate Officer/Principal | |
Sichuan Kelun Pharmacy Institute Co., Ltd.
 Sichuan Kelun Pharmacy Institute Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1998, Sichuan Kelun Pharmacy Institute Co., Ltd. is a subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd. The company is based in Chengdu, China and manufactures medicines. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Chongqing Medical University | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
| Sichuan Kelun Industry Group Co., Ltd. | Chairman Director/Board Member Director/Board Member | ||
| Sichuan University | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
| Fourth Military Medical University | College/University | Graduate Degree Undergraduate Degree | |
| YILI CHUANNING BIOTECHNOLOGY CO.,LTD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Chengdu Qingshan Likang Pharmaceutical Co., Ltd. | Chairman Director/Board Member | ||
| University of Leeds | College/University | Graduate Degree Doctorate Degree | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ClinChoice, Inc.
 ClinChoice, Inc. BiotechnologyHealth Technology ClinChoice, Inc. operates as Contract Research Organization. The firm offers data management, biostatistics, statistical programming, CDISC compliant ESubmission, pharmacovigilance, medical writing, and clinical operations to the pharmaceutical, biotechnology, and medical device industries worldwide. The company was founded by Xin Ke and Henry Wu in 1995 and is headquartered in Fort Washington, PA. | Biotechnology | President | |
| University of Hong Kong | College/University | Corporate Officer/Principal | |
Beijing Advaccine Biotechnology Co., Ltd.
 Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | Biotechnology | Director/Board Member | |
| University of Minnesota School of Public Health | College/University | Doctorate Degree | |
| Washington State University | College/University | Graduate Degree | |
| Nanjing University | College/University | Undergraduate Degree | |
NASDAQ OMX Group, Inc.
 NASDAQ OMX Group, Inc. Financial ConglomeratesFinance NASDAQ OMX Group, Inc. provides investment services. | Financial Conglomerates | Chief Tech/Sci/R&D Officer | |
| MIGAO GROUP HOLDINGS LIMITED | Chemicals: Agricultural | Corporate Secretary | |
| AKESO, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
KLUS Pharma, Inc.
 KLUS Pharma, Inc. BiotechnologyHealth Technology KLUS Pharma, Inc. discovers and develops novel and safer antibody-based therapeutics. The firm specializes in global business development, biologics drug discovery and development, antibody discovery, antibody-drug conjugates(ADC), clinical development, bispecific, multispecific antibody and immuno-oncology. The company was founded in October 2014 and is headquartered in Cranbury, NJ. | Biotechnology | Director/Board Member | |
| Fudan University | College/University | Doctorate Degree | |
| East China University of Science & Technology | College/University | Graduate Degree | |
Ratiopharm GmbH
 Ratiopharm GmbH Pharmaceuticals: MajorHealth Technology ratiopharm GmbH engages in the production and distribution of generic drugs and pharmaceutical products. It offers pain relievers, nasal sprays, bronchial drops, as well as medicines for treating high blood pressure, cancer, pulmonary arterial hypertension, human immunodeficiency virus infection and acquired immune deficiency syndrome. The company was founded in 1973 and is headquartered in Ulm, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Boehringer Ingelheim Shanghai Pharmaceuticals Co. Ltd. | Corporate Officer/Principal | ||
Shanghai Heng Shou Tang Pharmaceutical Co. Ltd.
 Shanghai Heng Shou Tang Pharmaceutical Co. Ltd. Pharmaceuticals: OtherHealth Technology Shanghai Heng Shou Tang Pharmaceutical Co., Ltd. is a health care pharmaceutical company in China. It provides research & development, production & marketing of health foods & beverages. The company was founded in October 1997 and is headquartered in Shanghai, CN. | Pharmaceuticals: Other | Corporate Officer/Principal | |
| Shanghai Yan'an Pharmaceutical Factory | Corporate Officer/Principal | ||
| Shanghai Medical College of Fudan University | College/University | Undergraduate Degree | |
| Tsinghua University | College/University | Graduate Degree | |
| Academy of Military Medical Sciences | College/University | Graduate Degree | |
| University of International Business & Economics | College/University | Undergraduate Degree | |
Goldman Sachs Gao Hua Securities Co., Ltd.
 Goldman Sachs Gao Hua Securities Co., Ltd. Investment Banks/BrokersFinance Goldman Sachs Gao Hua Securities Co., Ltd. (GS-GHS) is a Beijing-based securities firm established in 2004 as a joint venture between the leading global investment banking, securities and investment management firm Goldman Sachs Group, Inc. (NYSE: GS) and the domestic securities firm Beijing Gao Hua Securities Co. Ltd., led by China-born banker Fang Fenglei. The Lenovo Group, China's largest computer manufacturer, was a key investor in GS-GHS, which was set-up through the acquisition of the operating license of the failed Hainan Securities. The presence of Goldman Sachs in Beijing dates back to 1993, and the creation of GS-GHS gave them a first-mover advantage in the Chinese securities market. GS-GHS offers a wide range of investment banking services to clients based in mainland China, including domestic securities brokerage and proprietary trading in equity, fixed income, currency and commodities. The firm underwrites locally-listed A-share transactions as well as RMB-denominated corporate bonds and convertible bonds. They also provide domestic financial advisory and other related services. The management team comprises Chinese and international investment bankers and securities professionals. | Investment Banks/Brokers | Director/Board Member | |
| Manchester Metropolitan University | College/University | Doctorate Degree | |
| Harbin Medical University | College/University | Undergraduate Degree | |
Duality Biopharmaceutical (Suzhou) Co., Ltd.
 Duality Biopharmaceutical (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Duality Biopharmaceutical (Suzhou) Co., Ltd. is a biopharmaceutical company based in Suzhou, China. The Chinese company was founded in 2020 by Zhong Yuan Zhu. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Harbour BioMed (Shanghai) Co., Ltd.
 Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Biotechnology | Corporate Officer/Principal | |
| Sichuan Agricultural University | College/University | Undergraduate Degree | |
| HITGEN INC. | Biotechnology | Corporate Officer/Principal | |
| Temple University (Pennsylvania) | College/University | Doctorate Degree | |
| University of Chinese Academy of Sciences | College/University | Graduate Degree | |
Chiral Quest (Suzhou) Co., Ltd.
 Chiral Quest (Suzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Chiral Quest (Suzhou) Co. Ltd. provides drug discovery services. It focuses on the development and manufacture of chiral catalysts, development of synthetic processes, and a technology applications platform. Its products include a, b, and Cyclicb-amino acids; b-hydroxy acids; chiral amines, alcohols, amino alcohols, and pyrrolidines; succinates; and achiral compounds, a-hydroxy acids, and APIs and intermediates. Chiral Quest has one manufacturing site in Jiangxi province, and three overseas offices in USA, Europe & India respectively. The company was founded by Xumu Zhang in 2000 and is headquartered in Suzhou, China. | Miscellaneous Commercial Services | Director/Board Member | |
| Kpmg Consulting China Co. Ltd. | Comptroller/Controller/Auditor | ||
| SHANGHAI MODEL ORGANISMS CENTER, INC. | Miscellaneous Commercial Services | Director/Board Member | |
Hangzhou Sciwind Biosciences Co., Ltd.
 Hangzhou Sciwind Biosciences Co., Ltd. BiotechnologyHealth Technology Hangzhou Sciwind Biosciences Co., Ltd. is a biopharmaceutical company based in Hangzhou, China. The Chinese company's product pipeline includes potentially first-in-class and drug candidates, such as the long-acting glp-1 peptide analog ecnoglutide (phase 3), oral glp-1 peptide analog xw004 (phase 1), and oral small molecule glp-1 receptor agonist xw014 (phase 1). Sciwind has developed multiple proprietary technologies, including oral peptide and inhaled protein therapeutic delivery platforms, and identified a series of drug candidates based on these core platform technologies. The company was founded in 2017 by Hai Pan, who has been the CEO since 2017. | Biotechnology | Director/Board Member | |
Shandong Bestcomm Pharmaceutical Co., Ltd.
 Shandong Bestcomm Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shandong Bestcomm Pharmaceutical Co., Ltd. is engaged in the research, development and production of domestic pharmaceutical technology. It also offers the development of various new drugs. The company was founded on August 2, 2000 and is headquartered in Jinan, China. | Miscellaneous Commercial Services | Director/Board Member | |
| Hexie Zhuorui Zhuhai Investment Management Co. Ltd. | Corporate Officer/Principal | ||
Shenzhen Investment Holdings Co., Ltd.
 Shenzhen Investment Holdings Co., Ltd. Financial ConglomeratesFinance Shenzhen Investment Holdings Co., Ltd. operates as a state-owned asset management company. Its business activities include management of properties, capital operation, investment and financing, transportation logistics, manufacturing and trading, and modern service industries. The company was founded on October 13, 2004 and is headquartered in Shenzhen, China. | Financial Conglomerates | Corporate Officer/Principal | |
| IDG Capital | Director/Board Member | ||
| Qinghai Nationalities University | College/University | Undergraduate Degree | |
| CASI PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| China | 37 |
| United States | 6 |
| United Kingdom | 5 |
| Hong Kong | 3 |
| Sweden | 2 |
Sectoral
| Consumer Services | 22 |
| Health Technology | 16 |
| Finance | 4 |
| Commercial Services | 4 |
| Process Industries | 2 |
Operational
| Director/Board Member | 54 |
| Corporate Officer/Principal | 27 |
| Independent Dir/Board Member | 23 |
| Graduate Degree | 19 |
| Undergraduate Degree | 15 |
Most connected contacts
| Insiders | |
|---|---|
| Wai Sum Fung | 16 |
| Yue Dong Li | 14 |
| Jin Ping Jin | 12 |
| Jun You Ge | 10 |
| Xue Bo Zeng | 10 |
| Ge Xin Liu | 9 |
| Hao Feng | 8 |
| Si Chuan Liu | 7 |
| Xiao Ping Jin | 7 |
| Jing Yi Wang | 6 |
| Xiang Yang Tan | 5 |
| Yi Feng | 5 |
| Yi Hong Liao | 5 |
| Qiang Zheng | 4 |
| Hong Mei Song | 4 |
- Stock Market
- Insiders
- Yan Qing
- Company connections
